Ponsiano Ocama

Summary

Country: Uganda

Publications

  1. ncbi request reprint Hepatitis B virus infection: current status
    Ponsiano Ocama
    Mulago Hospital, Kampala, Uganda
    Am J Med 118:1413. 2005
  2. doi request reprint Management of HIV and hepatitis C virus infections in resource-limited settings
    Ponsiano Ocama
    Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    Curr Opin HIV AIDS 6:539-45. 2011
  3. pmc Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005
    P Ocama
    Department of Medicine, Makerere University, Kampala, Uganda
    Br J Cancer 100:799-802. 2009
  4. pmc The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda
    Ponsiano Ocama
    Infectious Diseases Institute, Kampala, Uganda
    Afr Health Sci 8:8-12. 2008
  5. pmc Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda
    Ponsiano Ocama
    Department of Medicine, Makerere University, Uganda
    Afr Health Sci 8:80-4. 2008
  6. pmc Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda
    P Ocama
    Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
    Int J STD AIDS 21:553-7. 2010
  7. pmc Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda
    P Ocama
    Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    Afr Health Sci 11:S20-3. 2011
  8. ncbi request reprint The liver in HIV in Africa
    Jordan J Feld
    Infectious Disease Clinic, Department of Medicine, Mulago Hospital, Kampala, Uganda
    Antivir Ther 10:953-65. 2005
  9. ncbi request reprint Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda)
    Patricia Mwebaze Songa
    Infectious Diseases Institute, Makerere University, Kampala, Uganda
    Clin Infect Dis 45:514-7. 2007
  10. pmc Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?
    Barbara Castelnuovo
    Infectious Diseases Institute, Kampala, Uganda
    Afr Health Sci 8:133-4. 2008

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Hepatitis B virus infection: current status
    Ponsiano Ocama
    Mulago Hospital, Kampala, Uganda
    Am J Med 118:1413. 2005
    ..A decline in the prevalence of hepatitis B infection worldwide will require changes in high-risk behavior and the wider use of vaccination...
  2. doi request reprint Management of HIV and hepatitis C virus infections in resource-limited settings
    Ponsiano Ocama
    Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    Curr Opin HIV AIDS 6:539-45. 2011
    ..To provide an update on the epidemiology and management of HIV and hepatitis C virus (HCV) in resource-limited settings (RLSs)...
  3. pmc Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005
    P Ocama
    Department of Medicine, Makerere University, Kampala, Uganda
    Br J Cancer 100:799-802. 2009
    ..Investigations of viral hepatitis, aflatoxin, obesity, and human immunodeficiency virus (HIV) may help to explain the increasing incidence of hepatocellular carcinomas (HCCs)...
  4. pmc The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda
    Ponsiano Ocama
    Infectious Diseases Institute, Kampala, Uganda
    Afr Health Sci 8:8-12. 2008
    ..Liver diseases are common in patients with HIV due to viral hepatitis B and C co-infections, opportunistic infections or malignancies, antiretroviral drugs and drugs for opportunistic infections...
  5. pmc Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda
    Ponsiano Ocama
    Department of Medicine, Makerere University, Uganda
    Afr Health Sci 8:80-4. 2008
    ..Risk factors for this cancer have been identified but not studied systematically in Uganda. Identification of these factors would enable establishment of preventive measures...
  6. pmc Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda
    P Ocama
    Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
    Int J STD AIDS 21:553-7. 2010
    ..Male gender and CD4+ change from baseline were correlated with AST elevation. Patients with HIV/HBV co-infection were not at an increased risk of AST elevation, which occurred uncommonly in this setting...
  7. pmc Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda
    P Ocama
    Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    Afr Health Sci 11:S20-3. 2011
    ..Hepatitis B virus (HBV) is the commonest cause of primary hepatocellular (PHC) carcinoma worldwide. Co-infection with the HIV leads to more rapid progression of liver disease...
  8. ncbi request reprint The liver in HIV in Africa
    Jordan J Feld
    Infectious Disease Clinic, Department of Medicine, Mulago Hospital, Kampala, Uganda
    Antivir Ther 10:953-65. 2005
    ..In this review we present the available data on liver disease in HIV-infected populations in Africa and discuss relevant data from the rest of the world. In addition, we highlight important areas for further study...
  9. ncbi request reprint Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda)
    Patricia Mwebaze Songa
    Infectious Diseases Institute, Makerere University, Kampala, Uganda
    Clin Infect Dis 45:514-7. 2007
    ..The median serum lactate level was 6.6 mmol/L. All patients had their antiretroviral treatment regimen discontinued. Hospital admission was required for 5 patients. Five patients died...
  10. pmc Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?
    Barbara Castelnuovo
    Infectious Diseases Institute, Kampala, Uganda
    Afr Health Sci 8:133-4. 2008
    ..In resource limited settings patients on antiretroviral treatment who develop stavudine induced hyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative...
  11. pmc Hepatitis B virus genotypes A and D in Uganda
    Jackie T Zirabamuzale
    Department of Medicine, Makerere University College of Health Sciences, Mulago Hospital, Kampala, Uganda
    J Virus Erad 2:19-21. 2016
    ..Hepatitis B virus genotypes impact on treatment response, rate of spontaneous recovery and progression of chronic HBV infection and hepatocellular carcinoma. There is little information on the HBV genotypic distribution in Uganda...
  12. pmc Initial description of immune reconstitution inflammatory syndrome involving the thyroid gland in an immunocompromised patient
    Christine Katusiime
    Department of Prevention, Counselling and Treatment, Makerere University, College of Health Sciences, Infectious Diseases Institute, Kampala, Uganda
    BMJ Case Rep 2011:. 2011
    ..The patient is still undergoing treatment...
  13. pmc Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review
    Christine Katusiime
    Makerere University, College of Health Sciences, Infectious Diseases Institute, Kampala, Uganda
    Afr Health Sci 14:679-81. 2014
    ..However, the successful long-term treatment of HIV/AIDS is under threat from the emergence of drug-resistant strains to multiple agents and entire drug classes...
  14. pmc High burden of hepatitis B infection in Northern Uganda: results of a population-based survey
    Emmanuel Ochola
    Clinical Epidemiology Unit, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
    BMC Public Health 13:727. 2013
    ..Childhood vaccination was rolled out in 2002, the effect of which on the burden of hepatitis B has not been examined. We determined the prevalence and risk factors for hepatitis B infection in the Northern Uganda Municipality of Gulu...
  15. doi request reprint Hepatitis B incidence and prevention with antiretroviral therapy among HIV positive individuals in Rakai, Uganda
    Emmanuel Seremba
    aSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda bClinical Research Directorate Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702 cRakai Health Sciences Program, Kalisizo, Uganda dJohns Hopkins Bloomberg School of Public Health, Baltimore, MD eFred Hutchinson Cancer Research Center and University of Washington, Seattle, WA fSchool of Public Health, Makerere University College of Health Sciences, Kampala, Uganda gJohns Hopkins University School of Medicine hDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
    AIDS . 2017
    ..We investigated the incidence and risk factors associated with HBV among HIV-infected adults in Rakai, Uganda...
  16. pmc Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda
    Ponsiano Ocama
    Makerere University College of Health Sciences, Department of Medicine, Gastroenterology Division, Mulago Hospital, Kampala, Uganda
    Afr Health Sci 15:328-33. 2015
    ..Burden of co-infection is unknown yet most patients are on lamivudine-only ART where resistance is frequent. Most patients are initiated on antiretroviral therapy (ART) without knowing their HBV status...
  17. pmc Traditional herbal medicine use associated with liver fibrosis in rural Rakai, Uganda
    Brandon J Auerbach
    Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda
    PLoS ONE 7:e41737. 2012
    ..Traditional herbal medicines are commonly used in sub-Saharan Africa and some herbs are known to be hepatotoxic. However little is known about the effect of herbal medicines on liver disease in sub-Saharan Africa...
  18. pmc Intractable chronic vulval ulceration presenting as immune reconstitution inflammatory syndrome in a treatment-failure patient: a case observation
    Christine Katusiime
    Department of Prevention, Care and Treatment, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
    Case Rep Obstet Gynecol 2011:896964. 2011
    ..To the best of our knowledge, this is the first reported case of intractable vulval ulceration IRIS in an HIV-1 treatment-failure patient...
  19. pmc Atypical presentation of colon adenocarcinoma: a case report
    Lynnette K Tumwine
    Department of Pathology, School of Biomedical Sciences, College of Health Sciences, Makerere University, P, O, Box 7072, Kampala, Uganda
    J Med Case Rep 6:58. 2012
    ..We describe the clinicopathological features of colorectal carcinoma in the case of a young man in Kampala, Uganda...